Neurostimulation device maker Nexalin stock drops 44% following $10M IPO

Like
Comment
Favorite

Neurostimulation device maker Nexalin stock drops 44% following $10M IPO

seekingalpha2022-09-17

Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

金錢弟
·2022-09-17
This IPO didn't look good
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2268161482?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-17 01:11","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2268161482","market":"us","top_or_hot":-1,"title":"Neurostimulation device maker Nexalin stock drops 44% following $10M IPO","media":"seekingalpha","content":"<div>\n<p>Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neurostimulation device maker Nexalin stock drops 44% following $10M IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeurostimulation device maker Nexalin stock drops 44% following $10M IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-17 01:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NXL","symbol_name":"Nexalin Technology, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo","article_id":"2268161482","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2268161482","pubTimestamp":1663348261,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device d","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NXL":"Nexalin Technology, Inc."},"translate_title":"神经刺激设备制造商Nexalin股价在1000万美元IPO后下跌44%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NXL":1},"content_text":"Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 per share. The stock recently changed hands at $2.34 at around 12:45 p.m. ET. Nexalin offered 2.3M units priced at $4.15 per unit, with each unit consisting of one share plus one warrant to buy one share at $4.15. Underwriters were granted a 45-day option to buy up to 347K additional shares and/or warrants at the IPO price. Maxim Group was serving as sole bookrunner. Based in Texas, Nexalin has been developing neurostimulation devices to treat mental health conditions such as anxiety, insomnia and depression.  For a more in-depth look at Nexalin, check out SA contributor Avisol Capital Partners’ “Nexalin: Neurostimulation Therapy for Anxiety and Insomnia.”","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9937945730,"gmtCreate":1663362326221,"gmtModify":1676537257591,"author":{"id":"3577147550207659","authorId":"3577147550207659","name":"金錢弟","avatar":"https://community-static.tradeup.com/news/f3b7f4f61fb8c80cae1f168a1a712413","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"This IPO didn't look good&nbsp;","listText":"This IPO didn't look good&nbsp;","text":"This IPO didn't look good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9937945730","repostId":2268161482,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}